Skip to main content
Clinical Trials/NCT04328051
NCT04328051
Unknown
N/A

Influence of the Implant-prosthetic Connection in the Marginal Bone Loss and Bacterial Leakage. A Randomized Controlled Trial

University of Barcelona1 site in 1 country105 target enrollmentJune 13, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
Dental Implant
Sponsor
University of Barcelona
Enrollment
105
Locations
1
Primary Endpoint
Change in Vertical Marginal Bone Loss (VMBL)
Last Updated
6 years ago

Overview

Brief Summary

This study consists in a double-blinded randomized controlled trial which objective is to assess the effect of the implant-abutment connection type -external hexagon, internal hexagon and conical connection- in the periimplant marginal bone loss in vertical side and the bacterial leakage 12 months after prosthesis placement.

Detailed Description

Location: This study is going to take place in the Dentistry Hospital of the University of Barcelona (Campus of Bellvitge). Study subjects: The sample (105 patients) consists of patients with single tooth edentulous spaces or posterior maxillary and/or mandible edentulous spaces in need of dental implants with screw-retained single fixed crowns. All of them are being properly informed about the study according to the Comité Ético (CEIC) del Hospital Odontològic Universitat de Barcelona guidelines, and informed consent must be signed prior to the interventions. Material: Registration papers for the study, dental implants, surgery material, prosthetic components, Florida Probe Software®, Periapical x-rays, computer, Software Stata 14 and Software ImageJ®. Determinations: Clinical, radiographic and microbiologic measures since implant placement, prosthesis placement and 3, 6, 9 and 12 months after it.

Registry
clinicaltrials.gov
Start Date
June 13, 2018
End Date
December 13, 2021
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Octavi Camps-Font

Professor

University of Barcelona

Eligibility Criteria

Inclusion Criteria

  • Subjects who accept signing voluntarily the informed consent before doing any action related to the study.
  • ≥18-years-old patients.
  • Edentulous single spaces or edentulous posterior maxilla or mandible (from the first premolar to the second molar) with screw-retained single fixed crowns.
  • Single implants successfully osseointegrated placed at least 16 weeks post-extraction.
  • O'Leary plaque index and or bleeding on probing ≤25%.
  • Dental implants with screwed-retained prosthesis.

Exclusion Criteria

  • Systemic diseases that can interfere dental implant placement.
  • Any contraindication for surgery procedures.
  • Heavy smokers (\> 20cig/day).
  • Background of drug abuse or other factors such as psychiatric diseases that, in opinion of the examiner, could interfere with the ability of the patient to cooperate and compliment with the study.
  • Patients who have had participated with another clinical trial the last 30 days.
  • Pregnant women or in lactation.
  • Patients with bad oral hygiene or not motivated.
  • Probing pockets depths with bleeding of ≥4 mm on a tooth adjacent to the edentulous space.
  • Guided bone regeneration required in the same time of the implant placement.

Outcomes

Primary Outcomes

Change in Vertical Marginal Bone Loss (VMBL)

Time Frame: Since implant placement (Timing 0) through study completion (Timing 5), an average of 1 year.

Distance in millimetres between the implant platform and the point of the intra-bone defect that is more apical.

Secondary Outcomes

  • Early implant failure(Since implant placement (Timing 0) through prosthesis placement (Timing 1).)
  • Late implant failure(Since prosthesis placement (Timing 1) through study completion (Timing 5), an average of 1 year.)
  • Vertical Marginal Bone Loss Tax(12 months after prosthesis placement.)
  • Prosthetic complications(Since prosthesis placement (Timing 1) through study completion (Timing 5), an average of 1 year.)
  • Bacterial leakage(12 months after prosthesis placement.)
  • Probing pocket depth(Since prosthesis placement (Timing 1) through study completion (Timing 5), an average of 1 year.)
  • Mucosal recession(Since prosthesis placement (Timing 1) through study completion (Timing 5), an average of 1 year.)
  • Mucosal hyperplasia(Since prosthesis placement (Timing 1) through study completion (Timing 5), an average of 1 year.)
  • Clinical attachment level(Since prosthesis placement (Timing 1) through study completion (Timing 5), an average of 1 year.)
  • O'Leary plaque index(First visit)
  • Bleeding on probing(Since first visit through study completion (Timing 5), an average of 1 year.)
  • Suppuration on probing(Since first visit through study completion (Timing 5), an average of 1 year.)

Study Sites (1)

Loading locations...

Similar Trials